文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.

作者信息

Praveen Raj P, Gomes Rachel M, Kumar Saravana, Senthilnathan Palanisamy, Karthikeyan Purushothaman, Shankar Annapoorni, Palanivelu Chinnusamy

机构信息

Department of Bariatric Surgery, GEM Hospital and Research Centre, Tamil Nadu, India.

Department of Bariatric Surgery, GEM Hospital and Research Centre, Tamil Nadu, India.

出版信息

Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1315-22. doi: 10.1016/j.soard.2015.02.006. Epub 2015 Feb 11.


DOI:10.1016/j.soard.2015.02.006
PMID:26003897
Abstract

BACKGROUND: Surgically induced weight loss improves nonalcoholic fatty liver disease (NAFLD) in morbidly obese Caucasian patients. Similar data are lacking from India. OBJECTIVE: To compare the histologic features of NAFLD in morbidly obese Indian patients before and 6 months after bariatric surgery. Histologic changes were also separately assessed according to the type of bariatric intervention. SETTING: Teaching institution, India; private practice. METHODS: All patients undergoing bariatric surgery from July 2012 to July 2013 underwent a routine liver biopsy at the time of bariatric surgery. If the biopsy specimen indicated NAFLD, patients were asked to undergo a second biopsy after 6 months. Baseline anthropometry, clinical data, biochemistry, and pathology were recorded and repeated at follow-up. RESULTS: Eighty-eight of 134 index biopsy specimens indicated NAFLD. Thirty patients had paired liver biopsies. Steatosis was present in all, 14 had lobular inflammation, 10 had ballooning degeneration, and 14 had fibrosis. Mean time between the biopsies was 7.1 months (range 6-8 months). At the second biopsy, steatosis had resolution in 19 and improvement in 11, lobular inflammation had resolution in 12 and improvement in 2, ballooning had resolution in 9 and improvement in 1 and fibrosis had resolution in 11 and improvement in 3 (P<0.05 for all). Improvement was greater among those who underwent a sleeve gastrectomy in comparison to a Roux-en-Y gastric bypass, although this difference was not statistically significant. None had worsening of liver histologic results. CONCLUSIONS: Surgically induced weight loss significantly and rapidly improves liver histology in morbidly obese Indians with NAFLD.

摘要

相似文献

[1]
The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: "NASHOST" prospective observational trial.

Surg Obes Relat Dis. 2015

[2]
Surgery for weight loss in adults.

Cochrane Database Syst Rev. 2014-8-8

[3]
Bariatric surgery for non-alcoholic fatty liver disease in individuals with obesity (Base-NAFLD): protocol of a prospective multicenter observational follow-up study.

BMC Surg. 2021-6-24

[4]
Preoperative nonalcoholic steatohepatitis and resolution of metabolic comorbidities after bariatric surgery.

Surg Obes Relat Dis. 2024-12

[5]
Impact of Nonalcoholic Fatty Liver Disease (NAFLD) on Weight Loss After Bariatric Surgery.

Obes Surg. 2023-12

[6]
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.

Health Technol Assess. 2009-9

[7]
Association of Sex Differences on Weight Loss and Complications Following Bariatric Surgery.

J Surg Res. 2024-7

[8]
Bariatric surgery in morbidly obese patients with inflammatory bowel disease: A systematic review.

Surg Obes Relat Dis. 2017-4

[9]
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology.

Obes Surg. 2015-12

[10]
Higher Pre-Operative Non-Invasive Fibrosis Scores are not Associated with Surgical Outcomes in Patients with MASLD Undergoing Metabolic and Bariatric Surgery.

Can Liver J. 2025-2-12

引用本文的文献

[1]
Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.

Commun Med (Lond). 2025-7-28

[2]
Prior metabolic and bariatric surgery is an independent determinant of severity of decompensation in alcohol-associated liver disease.

United European Gastroenterol J. 2024-12

[3]
Foregut bypass restrictive bariatric procedures for nonalcoholic fatty liver disease: a meta-analysis of 3,355 individuals.

Hepatobiliary Surg Nutr. 2023-10-1

[4]
Nonalcoholic liver disease: Epidemiology, risk factors, natural history, and management strategies.

Ann N Y Acad Sci. 2023-8

[5]
Impact of pre-operative weight loss on non-alcoholic fatty liver disease histopathology and insulin resistance in individuals undergoing bariatric surgery: a propensity matched cross-sectional comparison.

Sao Paulo Med J. 2024

[6]
Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota.

Langenbecks Arch Surg. 2023-2-24

[7]
Combined non-alcoholic fatty liver disease and type 2 diabetes in severely obese patients-medium term effects of sleeve gastrectomy versus Roux-en-Y-gastric bypass on disease markers.

Hepatobiliary Surg Nutr. 2022-12

[8]
Bariatric endoscopic-surgical therapies for NAFLD. Should they be considered viable options among current treatments?

Front Endocrinol (Lausanne). 2022

[9]
The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

J Clin Med. 2022-3-2

[10]
Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.

J Clin Med. 2021-8-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索